Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Asthma

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 58 articles:
HTML format



Single Articles


    November 2021
  1. FAN Q, Ong ASE, Koh MS, Doshi K, et al
    The mediating role of trust in physician and self-efficacy in understanding medication adherence in severe asthma.
    Respir Med. 2021;190:106673.
    PubMed     Abstract available


    October 2021
  2. ROGLIANI P, Ritondo BL, Puxeddu E, Cazzola M, et al
    Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review.
    Respir Med. 2021;189:106639.
    PubMed     Abstract available


    September 2021
  3. DE BOER GM, Tramper-Stranders GA, Houweling L, van Zelst CM, et al
    Adult but not childhood onset asthma is associated with the metabolic syndrome, independent from body mass index.
    Respir Med. 2021;188:106603.
    PubMed     Abstract available


  4. ROGLIANI P, Beasley R, Cazzola M, Calzetta L, et al
    SMART for the treatment of asthma: A network meta-analysis of real-world evidence.
    Respir Med. 2021;188:106611.
    PubMed     Abstract available


    August 2021
  5. AL-AHMAD M, Nurkic J, Othman Y, Jusufovic E, et al
    Severe asthma in Kuwait population: Phenotype-based approach.
    Respir Med. 2021;187:106586.
    PubMed     Abstract available


  6. CAPSTICK TG, Azeez NF, Deakin G, Goddard A, et al
    Ward based inhaler technique service reduces exacerbations of asthma and COPD.
    Respir Med. 2021;187:106583.
    PubMed     Abstract available


  7. GAGNE M, Lam Shin Cheung J, Kouri A, FitzGerald JM, et al
    A patient decision aid for mild asthma: Navigating a new asthma treatment paradigm.
    Respir Med. 2021 Aug 10:106568. doi: 10.1016/j.rmed.2021.106568.
    PubMed     Abstract available


    July 2021
  8. VEDEL-KROGH S, Nielsen SF, Nordestgaard BG, Lange P, et al
    Asthma and COPD versus phenotypic traits: Toward precision medicine in chronic airway disease.
    Respir Med. 2021;186:106529.
    PubMed     Abstract available


    June 2021
  9. THI LAM H, Van Tuong N, Sy DQ, Lundback B, et al
    Bronchial hyperresponsiveness is common in Hanoi, Vietnam: Asthma probably underdiagnosed.
    Respir Med. 2021;186:106513.
    PubMed     Abstract available


  10. ZHANG M, Jin M, Zhou X, Lin J, et al
    Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in China.
    Respir Med. 2021;186:106522.
    PubMed     Abstract available


  11. CHAPMAN KR, An L, Bosnic-Anticevich S, Campomanes CM, et al
    Asthma patients' and physicians' perspectives on the burden and management of asthma.
    Respir Med. 2021;186:106524.
    PubMed     Abstract available


  12. SCHYLLERT C, Andersson M, Backman H, Lindberg A, et al
    Childhood onset asthma is associated with lower educational level in young adults - A prospective cohort study.
    Respir Med. 2021;186:106514.
    PubMed     Abstract available


  13. YOUSIF A, Forget A, Beauchesne MF, Lemiere C, et al
    Development of an operational definition of treatment escalation in adults with asthma adapted to healthcare administrative databases: A Delphi study.
    Respir Med. 2021;185:106510.
    PubMed     Abstract available


  14. DUCHENE B, Caffry S, Kaminsky DA, Que LG, et al
    Functional significance of 8-isoprostanes in sinonasal disease and asthma.
    Respir Med. 2021;185:106506.
    PubMed     Abstract available


  15. RODRIGUES AT, Romano S, Romao M, Figueira D, et al
    Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial.
    Respir Med. 2021;185:106507.
    PubMed     Abstract available


  16. GARCIA-PACHON E, Ruiz-Alcaraz S, Baeza-Martinez C, Zamora-Molina L, et al
    Symptoms in patients with asthma infected by SARS-CoV-2.
    Respir Med. 2021;185:106495.
    PubMed     Abstract available


  17. SADEGHDOUST M, Mirsadraee M, Aligolighasemabadi F, Khakzad MR, et al
    Effect of azithromycin on bronchial wall thickness in severe persistent asthma: A double-blind placebo-controlled randomized clinical trial.
    Respir Med. 2021;185:106494.
    PubMed     Abstract available


  18. CRIMI C, Campisi R, Nolasco S, Cacopardo G, et al
    Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study.
    Respir Med. 2021;185:106491.
    PubMed     Abstract available


    May 2021
  19. ANDUJAR-ESPINOSA R, Aparicio-Vicente M, Ruiz-Lopez FJ, Salinero-Gonzalez L, et al
    Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial.
    Respir Med. 2021;185:106484.
    PubMed     Abstract available


  20. LISSPERS K, Stallberg B, Larsson K, Janson C, et al
    Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients' data using machine learning - Based on the ARCTIC study.
    Respir Med. 2021;185:106483.
    PubMed     Abstract available


    April 2021
  21. TIOTIU A, Ioan I, Poussel M, Schweitzer C, et al
    Comparative analysis between available challenge tests in the hyperventilation syndrome.
    Respir Med. 2021;179:106329.
    PubMed     Abstract available


    March 2021
  22. YE L, Gao X, Tu C, Du C, et al
    Comparative analysis of effectiveness of asthma control test-guided treatment versus usual care in patients with asthma from China.
    Respir Med. 2021;182:106382.
    PubMed     Abstract available


  23. CHALITSIOS CV, Shaw DE, McKeever TM
    Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis.
    Respir Med. 2021;181:106374.
    PubMed     Abstract available


  24. SAFAVI S, Munidasa S, Zanette B, Dai R, et al
    Evaluating post-bronchodilator response in well-controlled paediatric severe asthma using hyperpolarised 129Xe-MRI: A pilot study.
    Respir Med. 2021;180:106368.
    PubMed     Abstract available


  25. KAGOHASHI K, Miyazaki K, Satoh H
    Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics.
    Respir Med. 2021 Mar 6:106358. doi: 10.1016/j.rmed.2021.106358.
    PubMed    


  26. MENDY A, Wu X, Keller JL, Fassler CS, et al
    Long-term exposure to fine particulate matter and hospitalization in COVID-19 patients.
    Respir Med. 2021;178:106313.
    PubMed     Abstract available


    February 2021
  27. UNNI EJ, Gupta S, Sternbach N
    Using the Medication Adherence Reasons Scale (MAR-Scale) in asthma and chronic obstructive pulmonary disease to determine the extent and identify the reasons for non-adherence.
    Respir Med. 2021;179:106337.
    PubMed     Abstract available


    January 2021
  28. SCOSYREV E, van Zyl-Smit R, Kerstjens H, Gessner C, et al
    Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
    Respir Med. 2021;180:106311.
    PubMed     Abstract available


  29. SOL IS, Jang H, Noh J, Kim SY, et al
    Mortality and morbidity in children with asthma: A nationwide study in Korea.
    Respir Med. 2021;177:106306.
    PubMed     Abstract available


  30. LIAO SY, Petrache I, Fingerlin TE, Maier LA, et al
    Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases.
    Respir Med. 2021;176:106275.
    PubMed     Abstract available


  31. CAZZOLA M, Ora J, Bianco A, Rogliani P, et al
    Guidance on nebulization during the current COVID-19 pandemic.
    Respir Med. 2021;176:106236.
    PubMed     Abstract available


  32. ZELL-BARAN LM, Krefft SD, Moore CM, Wolff J, et al
    Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.
    Respir Med. 2021;176:106281.
    PubMed     Abstract available


  33. BJERRUM AS, Skjold T, Schmid JM
    Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment.
    Respir Med. 2021;176:106260.
    PubMed     Abstract available


    December 2020
  34. EGER K, Hashimoto S, Braunstahl GJ, Brinke AT, et al
    Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy.
    Respir Med. 2020;177:106287.
    PubMed     Abstract available


    November 2020
  35. KUPCZYK M, Majak P, Kuna P, Asankowicz-Bargiel B, et al
    A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical
    Respir Med. 2020;176:106274.
    PubMed     Abstract available


  36. TERVONEN T, Martinez FJ, Hanania NA, Heidenreich S, et al
    Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.
    Respir Med. 2020;176:106278.
    PubMed     Abstract available


  37. PULLERITS T, Ronmark EP, Ekerljung L, Palmqvist MA, et al
    The triad of current asthma, rhinitis and eczema is uncommon among adults: Prevalence, sensitization profiles, and risk factors.
    Respir Med. 2020;176:106250.
    PubMed     Abstract available


  38. CAMINATI M, Vultaggio A, Matucci A, Senna G, et al
    Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity.
    Respir Med. 2020;176:106261.
    PubMed     Abstract available


  39. BASSAM M, Behbehani N, Farouk H, Alsayed M, et al
    Adherence to medication among adult asthma patients in the Middle East and North Africa: results from the ESMAA study.
    Respir Med. 2020;176:106244.
    PubMed     Abstract available


  40. COTTINI M, Licini A, Lombardi C, Berti A, et al
    Prevalence and features of IOS-defined small airway disease across asthma severities.
    Respir Med. 2020;176:106243.
    PubMed     Abstract available


  41. LOMMATZSCH M, Sauerbeck IS, Wilmer C, Taube C, et al
    Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany.
    Respir Med. 2020;176:106242.
    PubMed     Abstract available


  42. HUSSEIN MH, Toraih EA, Attia AS, Burley N, et al
    Asthma in COVID-19 patients: An extra chain fitting around the neck?
    Respir Med. 2020;175:106205.
    PubMed     Abstract available


  43. GRAFF S, Bricmont N, Moermans C, Henket M, et al
    Clinical and biological factors associated with irreversible airway obstruction in adult asthma.
    Respir Med. 2020;175:106202.
    PubMed     Abstract available


  44. MOHR A, Plentz A, Sieroslawski A, Pezenburg F, et al
    Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany.
    Respir Med. 2020;174:106207.
    PubMed     Abstract available


  45. RAISANEN P, Hedman L, Andersson M, Stridsman C, et al
    Non-response did not affect prevalence estimates of asthma and respiratory symptoms - results from a postal questionnaire survey of the general population.
    Respir Med. 2020;173:106017.
    PubMed     Abstract available


  46. FEDDEMA JJ, Claassen E
    Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis.
    Respir Med. 2020;173:106020.
    PubMed     Abstract available


    October 2020
  47. QIN L, Li Z, Fan Y, Fang X, et al
    Exploration of plasma interleukin-27 levels in asthma patients and the correlation with lung function.
    Respir Med. 2020;175:106208.
    PubMed     Abstract available


  48. PAOLETTI G, Keber E, Heffler E, Malipiero G, et al
    Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma.
    Respir Med. 2020;174:106199.
    PubMed     Abstract available


  49. GESSNER C, Kornmann O, Maspero J, van Zyl-Smit R, et al
    Corrigendum to "Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority stu
    Respir Med. 2020 Oct 17:106186. doi: 10.1016/j.rmed.2020.106186.
    PubMed    


  50. LITT HK, Press VG, Hull A, Siros M, et al
    Association between inhaler technique and confidence among hospitalized children with asthma.
    Respir Med. 2020;174:106191.
    PubMed     Abstract available


  51. MORILLO-VANEGAS D, Sanchez-Salcedo P, Sebastian Arino AF
    Relationship between pediatric asthma and psychosocial status of caregivers.
    Respir Med. 2020;174:106187.
    PubMed     Abstract available


    September 2020
  52. LASSMANN-KLEE PG, Piirila PL, Brumpton B, Larsson M, et al
    Parallel gradients in FENO and in the prevalences of asthma and atopy in adult general populations of Sweden, Finland and Estonia - A Nordic EpiLung study.
    Respir Med. 2020;173:106160.
    PubMed     Abstract available


  53. BUSBY J, Khoo E, Pfeffer PE, Mansur AH, et al
    The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis.
    Respir Med. 2020;173:106156.
    PubMed     Abstract available


  54. FOSTER JM, Beasley R, Braithwaite I, Harrison T, et al
    Patient experiences of as-needed budesonide-formoterol by Turbuhaler(R) for treatment of mild asthma; a qualitative study.
    Respir Med. 2020;175:106154.
    PubMed     Abstract available


    August 2020
  55. IELPO A, Crisafulli E, Alcaraz-Serrano V, Gabarrus A, et al
    Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience.
    Respir Med. 2020;172:106090.
    PubMed     Abstract available


  56. ARO M, Saaresranta T, Vahlberg T, Anttalainen U, et al
    Medication of comorbidities in females with sleep-disordered breathing during long-term CPAP therapy.
    Respir Med. 2020;169:106014.
    PubMed     Abstract available


  57. AGONDI RC, Dias GMFS, Assis JP, Pacheco R, et al
    Hypersensitivity to dipyrone in aspirin-exacerbated respiratory disease patients is associated with urticaria.
    Respir Med. 2020;170:106041.
    PubMed     Abstract available


    May 2020
  58. BEZERRA DE MENEZES M, Ponte EV, Bertagni Mingotti CF, Carvalho Pinto RM, et al
    Provision of inhaled corticosteroids is associated with decrease in hospital admissions in Brazil: A longitudinal nationwide study.
    Respir Med. 2020;166:105950.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: